This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Czarniecki, C W Articles by Estell, D A Search for Related Content PubMed PubMed Citation Articles by Czarniecki, C W Articles by Estell, D A

 Previous Article  |  Next Article 

J Virol. 1984 February; 49(2): 490-496

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.

ABSTRACT

The antiviral and antiproliferative effects of highly purified Escherichia coli-derived human interferons (IFNs) were examined in human melanoma cells (Hs294T). Antiproliferative activity was monitored by measuring inhibition of cell multiplication, and antiviral activity was determined by inhibition of herpes simplex virus type 1 replication. Treatment of cells with IFN-gamma in combination with IFN-alpha A or IFN-beta 1 resulted in potentiation of both antiproliferative and antiviral activities. In contrast, combination treatments composed of IFN-alpha A and IFN beta 1 yielded inconsistent results. Some combinations reflected additive responses, whereas others were antagonistic. To examine correlations between IFN-induced biological activities and interactions of the different IFNs with cell surface receptors, in vivo [35S]methionine-labeled IFN-alpha A was prepared. Binding studies indicated the presence of 2,980 +/- 170 receptors per cell, each with an apparent Kd of (8.4 +/- 1.3) X 10(-11) M. Results from competitive binding studies suggested that Hs294T cells possess at least two types of IFN receptors: one which binds IFN-alpha A and IFN-beta 1 and another to which IFN-gamma binds.

This article has been cited by other articles:

• Davis, T. M. E., Hamzah, J., Ilett, K. F., Karunajeewa, H. A., Reeder, J. C., Batty, K. T., Hackett, S., Barrett, P. H. R. (2006). In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs.. Antimicrob. Agents Chemother. 50: 2883-2885 [Abstract] [Full Text]  
• Sainz, B. Jr, Halford, W. P. (2002). Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1. J. Virol. 76: 11541-11550 [Abstract] [Full Text]  
• Shtrichman, R., Heithoff, D. M., Mahan, M. J., Samuel, C. E. (2002). Tissue Selectivity of Interferon-Stimulated Gene Expression in Mice Infected with Dam+ versus Dam-Salmonella enterica Serovar Typhimurium Strains. Infect. Immun. 70: 5579-5588 [Abstract] [Full Text]  
• Maloy, K. J., Burkhart, C., Junt, T. M., Odermatt, B., Oxenius, A., Piali, L., Zinkernagel, R. M., Hengartner, H. (2000). CD4+ T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability. J. Exp. Med. 191: 2159-2170 [Abstract] [Full Text]  
• Maloy, K. J., Burkhart, C., Freer, G., Rulicke, T., Pircher, H., Kono, D. H., Theofilopoulos, A. N., Ludewig, B., Hoffmann-Rohrer, U., Zinkernagel, R. M., Hengartner, H. (1999). Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection. J. Immunol. 162: 2867-2874 [Abstract] [Full Text]  
• Wong, L. H., Hatzinisiriou, I., Devenish, R. J., Ralph, S. J. (1998). IFN-{gamma} Priming Up-Regulates IFN-Stimulated Gene Factor 3 (ISGF3) Components, Augmenting Responsiveness of IFN-Resistant Melanoma Cells to Type I IFNs. J. Immunol. 160: 5475-5484 [Abstract] [Full Text]